🎉   Please check out our new website over at books-etc.com.

Seller
Your price
£67.82
RRP: £89.99
Save £22.17 (25%)
Printed on Demand
Dispatched within 14-21 working days.

Brain Tumor Stem Cells

Methods and Protocols. Methods in Molecular Biology 1869

Format: Hardback
Publisher: Humana Press Inc., Totowa, NJ, United States
Published: 16th Oct 2018
Dimensions: w 178mm h 254mm
Weight: 927g
ISBN-10: 1493988042
ISBN-13: 9781493988044
Barcode No: 9781493988044
Trade or Institutional customer? Contact us about large order quotes.
Synopsis
This detailed volume compiles the best methodologies and experimental techniques to profile and extract maximal data from brain tumor stem cells (BTSCs), the experimental paradigm for brain cancer research that offers insights into cancer stem cell populations that may drive not only tumor initiation but tumor recurrence and patient relapse. The BTSC model recapitulates scientific observations made in brain cancer patients, and these chapters provide the reader with a comprehensive understanding of the skills and techniques that will unlock data from this most informative subset of cells. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, Brain Tumor Stem Cells: Methods and Protocols serves as an ideal guide for researchers seeking to better understand the complexities of brain cancer.

New & Used

Seller Information Condition Price
-New£67.82
+ FREE UK P & P

What Reviewers Are Saying

Submit your review
Newspapers & Magazines
"Sheila K. Singh and Chitra Venugopal have developed a concise, systematic, and practical book; an ideal read for brain cancer researchers. ... this book is recommended for anyone who strives for proficiency in biophysiology of cancer stem cells and hopes to discover novel therapeutic and treatment strategies for patients affected by devastating CNS disease." (Angela M. Bohnen, Neurosurgery, Vol. 85 (4), October, 2019)